Zihan Li

Zihan Li

Auto-generated profile, based on publicly available information

Zihan Li

Northeastern University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
ZLZihan Li
Zihan Li
WZWenchang Zhao
Wenchang Zhao
SMShixin Ma
Shixin Ma
ZLZexu Li
Zexu Li
YYYingjia Yao
Yingjia Yao
TFTeng Fei
Teng Fei

10 February 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
XCXiaolong Cheng
Xiaolong Cheng
ZLZexu Li
Zexu Li
RSRuocheng Shan
Ruocheng Shan
ZLZihan Li
Zihan Li
SWShengnan Wang
Shengnan Wang
WLWei Li
Wei Li
A major challenge in the application of the CRISPR-Cas13d system is to accurately predict its guide-dependent on-target and off-target effect. Here, we perform CRISPR-Cas13d proliferation screens and design a deep learning model, named DeepCas13, to predict the on-target activity from guide sequences and secondary structures. DeepCas13 outperforms existing methods to predict the efficiency of guides targeting both protein-coding and non-coding RNAs. Guides targeting non-essential genes display off-target viability effects, which are closely related to their on-target efficiencies. Choosing proper negative control guides during normalization mitigates the associated false positives in proliferation screens. We apply DeepCas13 to the guides targeting lncRNAs, and identify lncRNAs that affect cell viability and proliferation in multiple cell lines. The higher prediction accuracy of DeepCas13 over existing methods is extensively confirmed via a secondary CRISPR-Cas13d screen and quantitative RT-PCR experiments. DeepCas13 is freely accessible via http://deepcas13.weililab.org.

29 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
CZChunge Zhong
Chunge Zhong
WJWen-Jie Jiang
Wen-Jie Jiang
YYYingjia Yao
Yingjia Yao
ZLZexu Li
Zexu Li
YLYou Li
You Li
TFTeng Fei
Teng Fei
Resistance to chemotherapy has been a major hurdle that limits therapeutic benefits for many types of cancer. Here we systematically identify genetic drivers underlying chemoresistance by performing 30 genome-scale CRISPR knockout screens for seven chemotherapeutic agents in multiple cancer cells. Chemoresistance genes vary between conditions primarily due to distinct genetic background and mechanism of action of drugs, manifesting heterogeneous and multiplexed routes towards chemoresistance. By focusing on oxaliplatin and irinotecan resistance in colorectal cancer, we unravel that evolutionarily distinct chemoresistance can share consensus vulnerabilities identified by 26 second-round CRISPR screens with druggable gene library. We further pinpoint PLK4 as a therapeutic target to overcome oxaliplatin resistance in various models via genetic ablation or pharmacological inhibition, highlighting a single-agent strategy to antagonize evolutionarily distinct chemoresistance. Our study not only provides resources and insights into the molecular basis of chemoresistance, but also proposes potential biomarkers and therapeutic strategies against such resistance.

23 October 2023 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
ZLZexu Li
Zexu Li
ZLZihan Li
Zihan Li
XCXiaolong Cheng
Xiaolong Cheng
SWShengnan Wang
Shengnan Wang
XWXiaofeng Wang
Xiaofeng Wang
TFTeng Fei
Teng Fei

1 March 2021 in iScience
Verified
Journal Article
Open access
ZLZexu Li
Zexu Li
YYYingjia Yao
Yingjia Yao
XCXiaolong Cheng
Xiaolong Cheng
QCQing Chen
Qing Chen
WZWenchang Zhao
Wenchang Zhao
TFTeng Fei
Teng Fei
RNA viruses are responsible for many zoonotic diseases that post great challenges for public health. Effective therapeutics against these viral infections remain limited. Here, we deployed a computational framework for host-based drug repositioning to predict potential antiviral drugs from 2,352 approved drugs and 1,062 natural compounds embedded in herbs of traditional Chinese medicine. By systematically interrogating public genetic screening data, we comprehensively cataloged host dependency genes (HDGs) that are indispensable for successful viral infection corresponding to 10 families and 29 species of RNA viruses. We then utilized these HDGs as potential drug targets and interrogated extensive drug-target interactions through database retrieval, literature mining, and de novo prediction using artificial intelligence-based algorithms. Repurposed drugs or natural compounds were proposed against many viral pathogens such as coronaviruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), flaviviruses, and influenza viruses. This study helps to prioritize promising drug candidates for in-depth evaluation against these virus-related diseases.

21 March 2024 in Journal of Building Engineering
Verified
Journal Article
Closed access
BXBaocheng Xiong
Baocheng Xiong
PNPing Nie
Ping Nie
HLHuanbao Liu
Huanbao Liu
XLXiaoxi Li
Xiaoxi Li
ZLZihan Li
Zihan Li
LWLiang Wang
Liang Wang